Vane's discovery of the mechanism of action of aspirin changed our understanding of its clinical pharmacology.
Journal Title: Pharmacological Reports - Year 2010, Vol 62, Issue 3
Abstract
Aspirin exerts its analgesic, antipyretic and anti-inflammatory actions by inhibiting the enzyme cyclooxygenase and thus preventing the formation and release of prostaglandins. The elucidation by John Vane of the mechanism of action of aspirin in 1971 was followed twenty years later by the discovery of a second cyclooxygenase enzyme, COX-2 and the rapid development of selective inhibitors of this enzyme. The COX-2 inhibitors are potent anti-inflammatory drugs without the damaging side effects on the stomach mucosa of the non-selective aspirin-like inhibitors. More recently, two enzymes have been identified inhibition of which may explain the mechanism of action of paracetamol. These are a putative cyclooxygenase-3 which is a variant of cyclooxygenase-1 and derives from the same gene, and a COX-2 variant, induced with diclofenac, which may be involved in the resolution of inflammation.
Authors and Affiliations
Regina Botting
Keywords
Related Articles
- EP ID EP107838
- DOI -
- Views 100
- Downloads 0
Is the mGlu5 receptor a possible target for new antidepressant drugs?
The current treatment of depression, based on conventional antidepressant drugs that influence monoaminergic systems, is not satisfactory, and innovative antidepressant drugs are still needed. The next generation of trea...
Zinc-induced adaptive changes in NMDA/glutamatergic and serotonergic receptors.
Preclinical data indicate the involvement of glutamatergic and serotonergic pathways in the antidepressant activity of zinc. The present study investigated alterations in N-methyl-D-aspartate (NMDA)/glutamatergic and ser...
Large and micro coronary vascular involvement in diabetes.
Diabetes, with hyperglycemia as its hallmark, is a major risk factor forischemic heart disease. The role of coronary disease in the adverse prognosis of diabetes is controversial although the higher prevalence and extens...
Effects of statins on nitric oxide/cGMP signaling in human umbilical vein endothelial cells.
Human umbilical vein endothelial cells (HUVECs) were established as in vitro models for the modulation of endothelial function and cell viability by statins. Emphasis was placed on the biphasic effects of the drugs on ni...
N-acetylcysteine inhibits IL-8 and MMP-9 release and ICAM-1 expression by bronchoalveolar cells from interstitial lung disease patients.
N-acetylcysteine (NAC), owing to its antioxidant, mucolytic and anti-inflammatory properties, is used in the treatment of various pulmonary disorders. However, the direct effects of NAC on bronchoalveolar lavage (BAL) ce...